Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

OBJECTIVES: To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib. METHODS: Phase II, III and long-term extension clinical trial data (April 2013 data-cut) from the tofacitinib RA programme were reviewed. OIs defined a priori inclu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Rheum Dis
Главные авторы: Winthrop, K L, Park, S-H, Gul, A, Cardiel, M H, Gomez-Reino, J J, Tanaka, Y, Kwok, K, Lukic, T, Mortensen, E, Ponce de Leon, D, Riese, R, Valdez, H
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2016
Предметы:
Clinical and Epidemiological Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893093/
https://ncbi.nlm.nih.gov/pubmed/26318385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-207319
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы